semaglutide and antipsychotics Semaglutide, a second-generation GLP-1 receptor agonist, was associated with significantly reduced body weight other metabolic factors in adults with schizophrenia, prediabetes, and overweight/obesity compared with placebo, research from September Semaglutide in Patients With Schizophrenia,

Additionally, GLP-1RAs exhibit pleiotropic effects on metabolic and cardiovascular pathways, which could influence arrhythmia risk through mechanisms such as glucose homeostasis, blood pressure regulation, and autonomic modulation

In the SURMOUNT-5 head-to-head trial in 2025, tirzepatide beat semaglutide directly, about 20.2% versus 13.7%

Getting started safely Tirzepatide, whether from Empower or any other source, requires a prescription from a licensed healthcare provider

(Weinh) 11, e2400843

However, many people prefer the flavor of ACV over other vinegars

sat down with Joe Rogan and dropped one of the biggest announcements in the history of functional wellness: roughly 14 of the 19 peptides the FDA had effectively banned from compounding pharmacies were coming back